Hedge Fund - Biotechnology Value Fund / BVF Inc
Protagonist Therapeutics Inc (PTGX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $131,729,365 | 3.29% | 5,744,848 | $17.50 |
| 2 | 2023 - Q3 (2023-09-30) | $95,824,065 | 2.58% | 5,744,848 | $19.40 |
| 3 | 2023 - Q2 (2023-06-30) | $104,290,358 | 2.9% | 3,775,900 | $25.03 |
| 4 | 2023 - Q1 (2023-03-31) | $86,845,700 | 3.17% | 3,775,900 | $16.79 |
| 5 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $9.46 |
| 6 | 2022 - Q2 (2022-06-30) | $8,755,000 | 0.42% | 1,106,838 | $12.09 |
| 7 | 2022 - Q1 (2022-03-31) | $99,059,000 | 3.96% | 4,183,219 | $28.17 |
| 8 | 2021 - Q4 (2021-12-31) | $124,890,000 | 4.53% | 3,651,759 | $31.61 |
| 9 | 2021 - Q3 (2021-09-30) | $69,139,000 | 2.69% | 3,901,759 | $42.63 |
| 10 | 2021 - Q2 (2021-06-30) | $168,484,000 | 6.31% | 3,754,095 | $33.01 |
| 11 | 2021 - Q1 (2021-03-31) | $102,550,000 | 3.84% | 3,959,451 | $25.31 |
| 12 | 2020 - Q4 (2020-12-31) | $86,156,000 | 3.38% | 4,273,588 | $21.52 |
| 13 | 2020 - Q3 (2020-09-30) | $46,378,000 | 2.52% | 2,372,288 | $18.76 |
| 14 | 2020 - Q2 (2020-06-30) | $41,806,000 | 2.57% | 2,367,288 | $12.55 |
| 15 | 2020 - Q1 (2020-03-31) | $4,889,000 | 0.45% | 692,430 | $7.49 |
| 16 | 2019 - Q4 (2019-12-31) | $4,813,000 | 0.36% | 682,630 | $9.93 |
| 17 | 2019 - Q3 (2019-09-30) | $8,198,000 | 0.86% | 682,630 | $12.60 |
| 18 | 2019 - Q2 (2019-06-30) | $12,883,000 | 1.4% | 1,063,802 | $11.06 |
| 19 | 2019 - Q1 (2019-03-31) | $14,119,000 | 1.58% | 1,123,255 | $8.83 |
| 20 | 2018 - Q4 (2018-12-31) | $11,034,000 | 1.44% | 1,639,458 | $7.93 |
| 21 | 2018 - Q3 (2018-09-30) | $26,939,000 | 2.36% | 2,617,967 | $8.61 |
| 22 | 2018 - Q2 (2018-06-30) | $9,529,000 | 0.93% | 1,417,967 | $7.68 |
| 23 | 2018 - Q1 (2018-03-31) | $3,484,000 | 0.35% | 405,600 | $18.83 |
| 24 | 2017 - Q4 (2017-12-31) | $6,118,000 | 0.73% | 294,117 | $17.74 |
| 25 | 2016 - Q4 (2016-12-31) | $0 | 0% | 0 | $22.30 |
| 26 | 2016 - Q3 (2016-09-30) | $7,924,000 | 1.49% | 375,000 | $13.67 |
The displayed share prices are average quarterly stock market prices.